(CIDRAP News) Albania today became the latest European country to confront H5N1 avian influenza in birds, while US officials reported plans to greatly expand testing of wild birds for the virus in Alaska and on the West Coast this spring.
(CIDRAP News) An unusual strain of Escherichia coli O157 that standard laboratory culture methods cannot detect has been identified in a disease outbreak associated with a nursery in Scotland and in other cases in Scotland and England, according to recent news reports.
(CIDRAP News) CSL Biotherapies, the US branch of an Australian vaccine producer, announced this week it has applied for Food and Drug Administration (FDA) approval to market a seasonal influenza vaccine in the United States.
(CIDRAP News) The Food and Drug Administration (FDA) today announced the approval of an Australian-made influenza vaccine called Afluria for use in adults, raising the number of US-licensed flu vaccines to six.
The vaccine, made by CSL Limited, based in Parkville, Australia, was approved for protecting people aged 18 and older from type A and B influenza viruses.
(CIDRAP News) European health officials today reported signs of an increasing rate of resistance to oseltamivir (Tamiflu) in Europe's predominant subtype of influenza virus, but they cautioned that the rate seen in isolates tested so far may not reflect the real situation.
(CIDRAP News) David Nabarro, influenza coordinator for the United Nations (UN), said during a press conference yesterday that the world is better prepared to respond to an influenza pandemic, but he added that continuing outbreaks in some countries are a reminder that a major threat remains.
(CIDRAP News) The United States will contribute another $44.4 million to the United Nations Food and Agriculture Organization's (FAO's) campaign to prevent and control avian influenza, the FAO announced today.